Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

NCT01463423 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

256

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

RADIATION: iSABR, 25 Gray in 1 fraction for small peripheral tumors
RADIATION: iSABR, 50 Gray in 4 fractions for medium peripheral tumors
RADIATION: iSABR, 54 Gray in 3 fractions for large peripheral tumors
RADIATION: iSABR, 40 Gray in 4 fractions for small central tumors
RADIATION: iSABR, 50 Gray in 4 fractions for medium central tumors
RADIATION: iSABR, 60 Gray in 8 fractions for large central tumors

Sponsor

Stanford University